Israel's LabStyle launches mobile phone blood sugar monitor

JERUSALEM Tue Mar 11, 2014 12:16pm EDT

Related Topics

JERUSALEM (Reuters) - Israeli start-up LabStyle Innovations Corp on Tuesday launched a mobile-phone glucose meter for diabetics to monitor their blood sugar levels.

Called Dario, the meter plugs directly into a smartphone and has a software application that gives real time recording and analysis of blood sugar readings.

The product is initially being launched in New Zealand, Italy, Australia and the United Kingdom. It will at first be available for Apple's iOS and later for Google's Android platform.

LayStyle said it was in the process of seeking insurance reimbursement approvals and expects the first approval by the end of June.

(Reporting by Steven Scheer)

FILED UNDER:
We welcome comments that advance the story through relevant opinion, anecdotes, links and data. If you see a comment that you believe is irrelevant or inappropriate, you can flag it to our editors by using the report abuse links. Views expressed in the comments do not represent those of Reuters. For more information on our comment policy, see http://blogs.reuters.com/fulldisclosure/2010/09/27/toward-a-more-thoughtful-conversation-on-stories/
Comments (2)
JIMFITZSR wrote:
DO YOU KNOW YOUR BLOOD PRESSURE, BLOOD SUGAR, INR, WEIGHT, BLOOD OXYGEN LEVELS?

THIS IS ONE OF THE TECH STEPS THAT WILL IMPROVE FOLKS HEALTH WHEN THIS INFORMATION IS AVAILABLE ON A DAILY BASIS FOR THE CONSUMER AND THE HEALTH CARE PROVIDER. I STARTED MONITORING MY BLOOD SUGAR AND ADJUSTED MY DIET AND LOST 30#.

Mar 11, 2014 2:30pm EDT  --  Report as abuse
JIMFITZSR wrote:
DO YOU KNOW YOUR BLOOD PRESSURE, BLOOD SUGAR, INR, WEIGHT, BLOOD OXYGEN LEVELS?

THIS IS ONE OF THE TECH STEPS THAT WILL IMPROVE FOLKS HEALTH WHEN THIS INFORMATION IS AVAILABLE ON A DAILY BASIS FOR THE CONSUMER AND THE HEALTH CARE PROVIDER. I STARTED MONITORING MY BLOOD SUGAR AND ADJUSTED MY DIET AND LOST 30#.

Mar 11, 2014 2:30pm EDT  --  Report as abuse
This discussion is now closed. We welcome comments on our articles for a limited period after their publication.